Related Experiment Videos
Shear wave elastography for detection of prostate cancer: a preliminary study
Sungmin Woo1, Sang Youn Kim1, Jeong Yeon Cho2
1Department of Radiology, Seoul National University Hospital, Seoul 110-744, Korea.
Korean Journal of Radiology
|May 21, 2014
Summary
Shear wave elastography (SWE) shows significant differences between prostate cancer and benign tissues, correlating with Gleason score. This technique aids in differentiating cancer aggressiveness and improving prostate cancer detection accuracy.
Area of Science:
- Urology
- Medical Imaging
- Oncology
Background:
- Prostate cancer diagnosis relies on prostate-specific antigen (PSA) levels and digital rectal examination (DRE).
- Biopsy remains the gold standard but has limitations in accuracy and sampling.
- Novel imaging techniques are needed to improve diagnostic precision.
Purpose of the Study:
- To evaluate the diagnostic performance of shear wave elastography (SWE) for detecting prostate cancer.
- To assess the correlation of SWE parameters with Gleason score and cancer aggressiveness.
Main Methods:
- Retrospective analysis of 87 patients with suspected prostate cancer undergoing systematic and targeted biopsies.
- Shear wave elastography (SWE) performed prior to biopsy, measuring mean stiffness (S) and mean stiffness ratio (R).
- Comparison of SWE parameters across different histopathologic tissues and correlation with Gleason scores.
Main Results:
- Prostate cancer was confirmed in 29.9% of patients and 7.5% of cores.
- SWE parameters (S and R) were significantly different between prostate cancer and benign tissues (p < 0.001).
- SWE demonstrated moderate accuracy for cancer diagnosis (ROC AUC 0.599 for S, 0.653 for R) and correlated with Gleason score (p ≤ 0.008).
Conclusions:
- Shear wave elastography parameters effectively differentiate prostate cancer from benign prostate tissue.
- SWE parameters correlate significantly with Gleason score, indicating potential for assessing cancer aggressiveness.
- SWE shows promise as an adjunct tool for improving prostate cancer detection and characterization.